Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
YPT-01 by Felix Biotechnology for Pseudomonas aeruginosa Infections: Likelihood of Approval
YPT-01 is under clinical development by Felix Biotechnology and currently in Phase II for Pseudomonas aeruginosa Infections. According to GlobalData,...
Data Insights
YPT-01 by Felix Biotechnology for Cystic Fibrosis: Likelihood of Approval
YPT-01 is under clinical development by Felix Biotechnology and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...